Top Stocks
Top Analyst Stocks
Top Smart Score Stocks
Top Insiders Stocks
Popular
Stock Screener
Top Online Growth Stocks
Trending Stocks
Penny Stock Screener
Dividend Investing
Dividend Calculator
Dividend Yield Calculator
Dividend Stocks
Dividend News
Dividend Calendar
ETFs
ETF Center
SPY ETF
QQQ ETF
Stock Comparison
ChatGPT Stocks
Value Stocks
Airline Stocks
AI Stocks
Oil Stocks
Bank Stocks
FAANG Stocks
Compare More Stocks…
Calendars
IPO Calendar
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
Market Holidays
Daily Analyst Ratings
Daily Insider Trading
Research Tools
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Stock Market News
Stock Analysis & Ideas
Popular
ETF News
Global Markets News
Expert Spotlight
TipRanks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
News
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
My Watchlist
Smart Portfolio
About Us
About TipRanks
Contact Us
Working with TipRanks
Enterprise Solutions
Best Online Brokers
Become an Affiliate
Follow Us
More
Plans
News
Smart Portfolio
Expert Center
Ideas
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed Tools
Try Now
Top Stocks
Smart Score Stocks
Analysts' Hot Stocks
Insiders' Hot Stocks
Popular
Trending Stocks
Fastest Growing Websites
Hot
Penny Stocks
Market Movers
Top Experts
My Experts
Top Firms
Top Wall Street Analysts
Top Financial Bloggers
Top Corporate Insiders
Popular
Top Hedge Fund Managers
Top Individual Investors
Research Tools
Stock Screener
Stock Comparison
Dividend Calculator
Popular
ETF Center
Dividend Yield Calculator
Daily Stock Ratings
Daily Insider Transactions
Comparisons
Stock Comparison
POPULAR COMPARISONS
Dividend Stocks
ChatGPT Stocks
Airline Stocks
AI Stocks
Smart Portfolio
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
Calendars
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
IPO Calendar
Stock Market Holidays
News
Market News
ETF News
Stock Analysis & Ideas
Popular
Global Markets News
Expert Spotlight
Tipranks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
About Us
About TipRanks
For Business
Become an Affiliate
Reviews
Contact Us
Plans & Pricing
OCUP
Stock Latest News
The Fly
Ocuphire Pharma announces APX3330 Phase 2 data presentations at retina meetings
1M ago
OCUP
The Fly
Ocuphire Pharma announces FDA acceptance of NDA for Nyxol
1M ago
OCUP
Market News
OCUP Tanks as Clinical Data Disappoints
2M ago
OCUP
The Fly
Ocuphire Pharma price target lowered to $20 from $26 at H.C. Wainwright
2M ago
OCUP
The Fly
Ocuphire craters 31% after trial evaluating oral APX3330 fails to meet endpoint
2M ago
OCUP
The Fly
Ocuphire Pharma did not meet the primary endpoint in Oral APX3330 trial
2M ago
OCUP
Press Releases
Ocuphire Announces Topline Results from ZETA-1 Phase 2 Trial of Oral APX3330 in Diabetic Retinopathy and Plans for End-of-Phase 2 Meeting with FDA
2M ago
OCUP
The Fly
Ocuphire Pharma enrolls first patient in VEGA-2 Phase 3 trial of Nyxol
3M ago
OCUP
Stock Analysis & Ideas
Analysts See Extravagant Gains for These 2 ‘Strong Buy’ Penny Stocks
3M ago
OCUP
RIGL
The Fly
Ocuphire Pharma submits NDA to FDA for Nyxol
4M ago
OCUP
Press Releases
Ocuphire Pharma Announces Submission of New Drug Application to FDA for Nyxol® Eye Drops for Reversal of Mydriasis
4M ago
OCUP
Press Releases
Ocuphire to Present at Five Upcoming Investor/Industry Conferences
4M ago
OCUP
The Fly
Ocuphire Pharma enters exclusive license agreement with FamyGen Life Sciences
5M ago
OCUP
VTRS
Press Releases
Ocuphire Announces Peer-Reviewed Publication in BMC Ophthalmology for Nyxol® and Strategic Partnership with American Society of Ophthalmic Administrators (ASOA)
5M ago
OCUP
Press Releases
Ocuphire Announces Six Poster Presentations on Nyxol and APX3330 at the American Academy of Optometry Annual Meeting
5M ago
OCUP
Press Releases
Ocuphire Pharma to Present at the MicroCap Rodeo Windy City Roundup 2022 Conference
6M ago
OCUP
Press Releases
Ocuphire Pharma Hosting Key Opinion Leader Event on Oral APX3330 for Diabetic Eye Disease
6M ago
OCUP
Press Releases
Ocuphire Expands Medical Advisory Board with Seven New KOLs and Strengthens Leadership Team
6M ago
OCUP
Press Releases
Ocuphire Pharma Announces Last Patient Completes Final Visit in ZETA-1 Phase 2b 24-Week Trial of Oral APX3330 in Diabetic Retinopathy
7M ago
OCUP
You need to enable JavaScript to run this app.